Bio-Techne (TECH) Total Current Liabilities (2010 - 2026)

Bio-Techne has reported Total Current Liabilities for 17 years, with the latest figure at $153.3 million in Q1 2026.

• For the quarter ending Q1 2026, Total Current Liabilities fell 9.41% year-over-year to $153.3 million; the trailing twelve-month figure through Mar 2026 stood at $153.3 million (down 9.41% YoY), and the FY2025 full-year result was $175.8 million, up 10.33% from the prior year.
• Total Current Liabilities for Q1 2026 stood at $153.3 million, up from $140.4 million in the prior quarter.
• The five-year high for Total Current Liabilities was $176.0 million in Q2 2022, with the low at $127.8 million in Q3 2023.
• Average Total Current Liabilities over 5 years is $149.3 million, with a median of $144.5 million recorded in 2025.
• Year-over-year, Total Current Liabilities retreated 26.99% in 2023 and climbed 24.02% in 2024.
• Tracing TECH's Total Current Liabilities over 5 years: stood at $128.4 million in 2022, then advanced by 5.32% to $135.2 million in 2023, then rose by 19.24% to $161.3 million in 2024, then decreased by 12.92% to $140.4 million in 2025, then climbed by 9.15% to $153.3 million in 2026.
• The last three Total Current Liabilities figures came in at $153.3 million (Q1 2026), $140.4 million (Q4 2025), and $144.5 million (Q3 2025), per Business Quant data.

Peer Comparison